Suppr超能文献

二尖瓣脱垂的遗传学与病理生理学

Genetics and pathophysiology of mitral valve prolapse.

作者信息

Delwarde Constance, Capoulade Romain, Mérot Jean, Le Scouarnec Solena, Bouatia-Naji Nabila, Yu Mengyao, Huttin Olivier, Selton-Suty Christine, Sellal Jean-Marc, Piriou Nicolas, Schott Jean-Jacques, Dina Christian, Le Tourneau Thierry

机构信息

Nantes Université, CHU Nantes, CNRS, INSERM, L'institut du Thorax, Nantes, France.

INSERM, PARCC, Université Paris Cité, Paris, France.

出版信息

Front Cardiovasc Med. 2023 Feb 16;10:1077788. doi: 10.3389/fcvm.2023.1077788. eCollection 2023.

Abstract

Mitral valve prolapse (MVP) is a common condition affecting 2-3% of the general population, and the most complex form of valve pathology, with a complication rate up to 10-15% per year in advanced stages. Complications include mitral regurgitation which can lead to heart failure and atrial fibrillation, but also life-threatening ventricular arrhythmia and cardiovascular death. Sudden death has been recently brought to the forefront of MVP disease, increasing the complexity of management and suggesting that MVP condition is not properly understood. MVP can occur as part of syndromic conditions such as Marfan syndrome, but the most common form is non-syndromic, isolated or familial. Although a specific X-linked form of MVP was initially identified, autosomal dominant inheritance appears to be the primary mode of transmission. MVP can be stratified into myxomatous degeneration (Barlow), fibroelastic deficiency, and Filamin A-related MVP. While FED is still considered a degenerative disease associated with aging, myxomatous MVP and FlnA-MVP are recognized as familial pathologies. Deciphering genetic defects associated to MVP is still a work in progress; although , , and have been identified as causative genes in myxomatous forms of MVP thanks to familial approaches, they explain only a small proportion of MVP. In addition, genome-wide association studies have revealed the important role of common variants in the development of MVP, in agreement with the high prevalence of this condition in the population. Furthermore, a potential genetic link between MVP and ventricular arrhythmia or a specific type of cardiomyopathy is considered. Animal models that allow to advance in the genetic and pathophysiological knowledge of MVP, and in particular those that can be easily manipulated to express a genetic defect identified in humans are detailed. Corroborated by genetic data and animal models, the main pathophysiological pathways of MVP are briefly addressed. Finally, genetic counseling is considered in the context of MVP.

摘要

二尖瓣脱垂(MVP)是一种常见病症,影响着2%至3%的普通人群,也是最复杂的瓣膜病变形式,在晚期每年的并发症发生率高达10%至15%。并发症包括二尖瓣反流,可导致心力衰竭和心房颤动,还包括危及生命的室性心律失常和心血管死亡。猝死最近已成为MVP疾病的突出问题,增加了管理的复杂性,并表明对MVP病症的认识并不充分。MVP可作为综合征性疾病的一部分出现,如马凡综合征,但最常见的形式是非综合征性、孤立性或家族性的。虽然最初确定了一种特定的X连锁形式的MVP,但常染色体显性遗传似乎是主要的遗传方式。MVP可分为黏液瘤样变性(巴洛氏病)、纤维弹性组织缺乏症和与细丝蛋白A相关的MVP。虽然纤维弹性组织缺乏症仍被认为是一种与衰老相关的退行性疾病,但黏液瘤样MVP和细丝蛋白A-MVP被认为是家族性疾病。解读与MVP相关的基因缺陷仍在进行中;尽管通过家族性研究已确定 、 和 是黏液瘤样形式的MVP的致病基因,但它们仅解释了一小部分MVP病例。此外,全基因组关联研究揭示了常见变异在MVP发病中的重要作用,这与该病症在人群中的高患病率相符。此外,还考虑了MVP与室性心律失常或特定类型心肌病之间的潜在遗传联系。详细介绍了有助于推进对MVP的遗传和病理生理学认识的动物模型,特别是那些可以轻松操纵以表达在人类中鉴定出的基因缺陷的模型。在遗传数据和动物模型的支持下,简要讨论了MVP的主要病理生理途径。最后,在MVP的背景下考虑了遗传咨询。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6494/9978496/e65f9af970dc/fcvm-10-1077788-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验